focus -WSS

focus

author：entertainment 2025-09-28 00:48:48 - browse：6

How does a drug industry lobbying group move forward after years of upheaval, including having four CEOs in four years?

This week on “The Readout LOUD,” STAT’s Chief Washington Correspondent Rachel Cohrs Zhang joins us to discuss the layoffs at trade group BIO and how things may be changing at the trade group. We also invite STAT reporter Eric Boodman on to talk about his new investigative series of stories exploring how Black women with sickle cell disease were coerced into getting sterilized.

To read the first article in the Coercive Care investigative series and find future installments, go here; For more on the layoffs at BIO, go here; To keep tabs on health policy and BIO’s reorganization, sign up for the D.C. Diagnosis newsletter here; And you can sign up for Adam’s new newsletter, Biotech Scorecard, here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

WSS

EpiPen alternative approval delay highlights citizen petition issue

Biotech lab space demand falls sharply

CDC advisers recommend seasonal use of Pfizer RSV shot

Dario to buy mental health app maker Twill in cash and stock deal

Ed Silverman on new gene therapies, biosimilars, coffee, and more

In utero gene editing: an explainer

Wikipedia

focus

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Senators: Long

Medicare details structure of new drug price negotiation program

R1 RCM gets $5.8 billion buyout offer from private equity firm

Moonlake's readout produced a cash windfall. Risks remain

Antivenom research: Lessons from HIV applied in search for universal antidote

Virginia high school admissions case could be legal follow

Alabama hospital puts IVF treatments on hold

Novavax promises a turnaround & Lilly roils the obesity market

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

leisure time

It's been 20 years since Dolly the sheep. Where's my clone?

It's been 20 years since Dolly the sheep. Where's my clone?

Hearing on Medicare drug price negotiation gets unusually heated

Medicare inequities exacerbate Puerto Rico’s health disparities

A new nitrogen execution bill also undermines medical licensing

The Harvard botanist who searched for psychedelics in the Amazon

hotspot

Wikipedia

hotspot

focus